Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nutrition Surveys | 4 | 2020 | 204 | 1.600 |
Why?
|
| Diet | 3 | 2020 | 513 | 1.230 |
Why?
|
| Nutritional Status | 3 | 2020 | 112 | 0.890 |
Why?
|
| Dietary Supplements | 3 | 2021 | 331 | 0.890 |
Why?
|
| Food, Fortified | 2 | 2019 | 38 | 0.850 |
Why?
|
| Nutritional Requirements | 2 | 2020 | 57 | 0.750 |
Why?
|
| Food Labeling | 1 | 2020 | 10 | 0.730 |
Why?
|
| Dietary Sugars | 1 | 2019 | 7 | 0.720 |
Why?
|
| Nutritive Value | 1 | 2019 | 22 | 0.710 |
Why?
|
| Beverages | 1 | 2019 | 50 | 0.690 |
Why?
|
| Energy Intake | 1 | 2019 | 123 | 0.670 |
Why?
|
| Feeding Behavior | 1 | 2019 | 224 | 0.610 |
Why?
|
| Models, Statistical | 1 | 2020 | 446 | 0.560 |
Why?
|
| Hypertension | 5 | 2021 | 1531 | 0.430 |
Why?
|
| Blood Pressure | 5 | 2021 | 1447 | 0.390 |
Why?
|
| Carpal Tunnel Syndrome | 3 | 2016 | 13 | 0.380 |
Why?
|
| Premature Birth | 2 | 2022 | 148 | 0.370 |
Why?
|
| Occupational Diseases | 3 | 2016 | 68 | 0.370 |
Why?
|
| Micronutrients | 2 | 2020 | 31 | 0.350 |
Why?
|
| Erectile Dysfunction | 2 | 2019 | 22 | 0.350 |
Why?
|
| Suicidal Ideation | 3 | 2019 | 106 | 0.310 |
Why?
|
| United States | 8 | 2021 | 7335 | 0.310 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2019 | 91 | 0.290 |
Why?
|
| Young Adult | 9 | 2021 | 5708 | 0.280 |
Why?
|
| Hypnotics and Sedatives | 2 | 2016 | 96 | 0.260 |
Why?
|
| Male | 19 | 2021 | 37281 | 0.240 |
Why?
|
| Emigrants and Immigrants | 2 | 2014 | 45 | 0.230 |
Why?
|
| Female | 18 | 2022 | 38015 | 0.230 |
Why?
|
| Penile Erection | 2 | 2019 | 18 | 0.230 |
Why?
|
| Child, Preschool | 2 | 2019 | 3185 | 0.210 |
Why?
|
| Adult | 13 | 2021 | 21375 | 0.210 |
Why?
|
| Fetal Diseases | 1 | 2022 | 64 | 0.210 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2022 | 46 | 0.210 |
Why?
|
| Humans | 24 | 2022 | 68525 | 0.210 |
Why?
|
| Adolescent | 6 | 2021 | 8903 | 0.210 |
Why?
|
| Obstetric Labor, Premature | 1 | 2022 | 76 | 0.210 |
Why?
|
| Hypoglycemia | 1 | 2022 | 72 | 0.200 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 91 | 0.200 |
Why?
|
| Safety-net Providers | 1 | 2021 | 20 | 0.200 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2021 | 41 | 0.200 |
Why?
|
| Resilience, Psychological | 1 | 2021 | 43 | 0.190 |
Why?
|
| Self Report | 3 | 2019 | 370 | 0.190 |
Why?
|
| Aged | 11 | 2021 | 14842 | 0.190 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 37 | 0.190 |
Why?
|
| Cross-Sectional Studies | 4 | 2019 | 2264 | 0.180 |
Why?
|
| Secondary Prevention | 1 | 2021 | 291 | 0.180 |
Why?
|
| Child Behavior | 1 | 2019 | 56 | 0.170 |
Why?
|
| Vitamin A | 1 | 2020 | 111 | 0.170 |
Why?
|
| Vitamins | 1 | 2020 | 134 | 0.170 |
Why?
|
| Age Factors | 3 | 2019 | 1860 | 0.170 |
Why?
|
| Enteral Nutrition | 1 | 2020 | 157 | 0.170 |
Why?
|
| Self Care | 1 | 2021 | 252 | 0.170 |
Why?
|
| Military Personnel | 1 | 2021 | 220 | 0.160 |
Why?
|
| Child | 2 | 2019 | 6400 | 0.160 |
Why?
|
| Middle Aged | 11 | 2021 | 21119 | 0.160 |
Why?
|
| Rivers | 1 | 2018 | 43 | 0.160 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 176 | 0.160 |
Why?
|
| Food-Processing Industry | 2 | 2013 | 3 | 0.150 |
Why?
|
| Medication Adherence | 2 | 2021 | 335 | 0.150 |
Why?
|
| Cognition | 1 | 2021 | 512 | 0.150 |
Why?
|
| Adolescent Behavior | 1 | 2019 | 264 | 0.150 |
Why?
|
| Environmental Monitoring | 1 | 2018 | 180 | 0.150 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2016 | 17 | 0.150 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2016 | 22 | 0.140 |
Why?
|
| Quality of Life | 2 | 2016 | 1515 | 0.140 |
Why?
|
| Temperature | 1 | 2018 | 340 | 0.140 |
Why?
|
| Oxygen | 1 | 2018 | 386 | 0.140 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 131 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 185 | 0.130 |
Why?
|
| Musculoskeletal Diseases | 1 | 2016 | 45 | 0.130 |
Why?
|
| Suicide | 1 | 2016 | 115 | 0.130 |
Why?
|
| Resistance Training | 1 | 2015 | 29 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2017 | 356 | 0.130 |
Why?
|
| Tinea Pedis | 1 | 2014 | 2 | 0.130 |
Why?
|
| Carpal Bones | 1 | 2014 | 7 | 0.130 |
Why?
|
| Meat-Packing Industry | 1 | 2014 | 3 | 0.130 |
Why?
|
| Onychomycosis | 1 | 2014 | 6 | 0.130 |
Why?
|
| Time Factors | 2 | 2021 | 4655 | 0.120 |
Why?
|
| Construction Industry | 1 | 2013 | 1 | 0.120 |
Why?
|
| Dermatitis, Occupational | 1 | 2013 | 5 | 0.120 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2013 | 14 | 0.120 |
Why?
|
| Telemedicine | 1 | 2021 | 699 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 497 | 0.110 |
Why?
|
| Weight Loss | 1 | 2014 | 319 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2022 | 2453 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 396 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2022 | 186 | 0.100 |
Why?
|
| Motor Activity | 1 | 2014 | 621 | 0.090 |
Why?
|
| Research Design | 1 | 2015 | 729 | 0.090 |
Why?
|
| Depressive Disorder, Major | 1 | 2015 | 438 | 0.090 |
Why?
|
| Exercise | 1 | 2015 | 657 | 0.090 |
Why?
|
| Stroke | 1 | 2021 | 2161 | 0.080 |
Why?
|
| Systole | 2 | 2019 | 149 | 0.080 |
Why?
|
| Logistic Models | 3 | 2016 | 1419 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2022 | 7264 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 1074 | 0.070 |
Why?
|
| Sexual Behavior | 2 | 2019 | 179 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1737 | 0.070 |
Why?
|
| Pregnancy | 2 | 2022 | 2331 | 0.070 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 648 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 2356 | 0.060 |
Why?
|
| North Carolina | 2 | 2014 | 224 | 0.060 |
Why?
|
| Incidence | 2 | 2019 | 1582 | 0.060 |
Why?
|
| Risk Factors | 3 | 2021 | 5719 | 0.050 |
Why?
|
| Betamethasone | 1 | 2022 | 24 | 0.050 |
Why?
|
| Steroids | 1 | 2022 | 84 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1548 | 0.050 |
Why?
|
| Sex Factors | 2 | 2016 | 1265 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2021 | 58 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2016 | 866 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 3702 | 0.050 |
Why?
|
| Phospholipids | 1 | 2021 | 108 | 0.050 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 84 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 186 | 0.050 |
Why?
|
| Smartphone | 1 | 2021 | 69 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 307 | 0.050 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2020 | 69 | 0.050 |
Why?
|
| Sleep Aids, Pharmaceutical | 1 | 2019 | 6 | 0.040 |
Why?
|
| Recommended Dietary Allowances | 1 | 2019 | 10 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2019 | 120 | 0.040 |
Why?
|
| Men's Health | 1 | 2019 | 8 | 0.040 |
Why?
|
| Mobile Applications | 1 | 2021 | 138 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 517 | 0.040 |
Why?
|
| Water Quality | 1 | 2018 | 15 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2020 | 284 | 0.040 |
Why?
|
| Income | 1 | 2019 | 165 | 0.040 |
Why?
|
| Fresh Water | 1 | 2018 | 43 | 0.040 |
Why?
|
| Hemorrhoids | 1 | 2017 | 5 | 0.040 |
Why?
|
| Peptic Ulcer | 1 | 2017 | 37 | 0.040 |
Why?
|
| Dabigatran | 1 | 2017 | 35 | 0.040 |
Why?
|
| Pyridones | 1 | 2017 | 40 | 0.040 |
Why?
|
| Seasons | 1 | 2018 | 129 | 0.040 |
Why?
|
| Rivaroxaban | 1 | 2017 | 26 | 0.040 |
Why?
|
| Arteriovenous Malformations | 1 | 2017 | 34 | 0.040 |
Why?
|
| Diverticulum | 1 | 2017 | 29 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 3256 | 0.040 |
Why?
|
| Warfarin | 1 | 2017 | 93 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 929 | 0.040 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2016 | 17 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2017 | 411 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2017 | 190 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 880 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2017 | 205 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2017 | 170 | 0.040 |
Why?
|
| Aspirin | 1 | 2017 | 295 | 0.030 |
Why?
|
| Community Health Planning | 1 | 2016 | 19 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 241 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 373 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 766 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 563 | 0.030 |
Why?
|
| Ideal Body Weight | 1 | 2014 | 4 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2004 | 0.030 |
Why?
|
| Poultry | 1 | 2014 | 14 | 0.030 |
Why?
|
| Wrist | 1 | 2014 | 24 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 107 | 0.030 |
Why?
|
| South Carolina | 1 | 2021 | 2750 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2014 | 46 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2013 | 24 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 2891 | 0.030 |
Why?
|
| Body Composition | 1 | 2014 | 119 | 0.030 |
Why?
|
| Patient Safety | 1 | 2015 | 202 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1745 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2014 | 222 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2014 | 453 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 955 | 0.030 |
Why?
|
| Hospitalization | 1 | 2017 | 977 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4843 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 1609 | 0.020 |
Why?
|
| Patient Selection | 1 | 2015 | 592 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1425 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 7028 | 0.020 |
Why?
|
| Animals | 1 | 2014 | 20877 | 0.010 |
Why?
|